Vascular Biogenics Ltd. Daily Stock Analysis

Daily Stock Analysis, VBLT, Vascular Biogenics Ltd, priceseries

Vascular Biogenics Ltd. Daily Stock Analysis
Stock Information
Open
1.30
Close
1.31
High
1.40
Low
1.23
Previous Close
1.39
Daily Price Gain
-0.08
YTD High
2.04
YTD High Date
Jan 4, 2022
YTD Low
1.13
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.62
YTD Gain
-32.12%
52 Week High
3.04
52 Week High Date
Jun 3, 2021
52 Week Low
1.13
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-0.53
52 Week Gain
-28.80%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 31. 2017
5.20
Feb 23. 2017
5.57
16 Trading Days
7.02%
Link
LONG
Sep 15. 2017
5.25
Sep 26. 2017
5.83
7 Trading Days
11.12%
Link
LONG
Sep 29. 2017
6.10
Oct 2. 2017
6.57
1 Trading Days
7.79%
Link
LONG
Nov 2. 2017
6.15
Nov 17. 2017
7.19
11 Trading Days
16.88%
Link
LONG
Dec 29. 2017
7.10
Jan 16. 2018
7.75
10 Trading Days
9.14%
Link
LONG
Jun 5. 2018
2.15
Jun 21. 2018
2.61
12 Trading Days
21.22%
Link
LONG
Jan 4. 2019
0.99
Feb 4. 2019
1.19
20 Trading Days
19.81%
Link
LONG
Feb 25. 2019
1.50
Mar 21. 2019
1.64
18 Trading Days
9.50%
Link
LONG
Dec 30. 2019
1.16
Jan 31. 2020
1.45
22 Trading Days
25.08%
Link
LONG
Jun 16. 2020
1.39
Jun 17. 2020
1.50
1 Trading Days
8.27%
Link
LONG
Nov 24. 2020
1.21
Dec 10. 2020
1.35
11 Trading Days
11.78%
Link
LONG
Feb 19. 2021
2.55
Feb 22. 2021
2.69
1 Trading Days
5.49%
Link
LONG
Apr 21. 2021
1.82
May 10. 2021
2.03
13 Trading Days
11.58%
Link
LONG
May 17. 2021
2.02
Jun 15. 2021
2.40
20 Trading Days
18.73%
Link
LONG
Aug 27. 2021
2.09
Sep 14. 2021
2.34
11 Trading Days
12.11%
Link
LONG
Oct 11. 2021
2.11
Nov 15. 2021
2.37
25 Trading Days
12.15%
Link
Company Information
Stock Symbol
VBLT
Exchange
NasdaqGM
Company URL
http://www.vblrx.com
Company Phone
972-3-6346450
CEO
Dror Harats
Headquarters
-
Business Address
6 JONATHAN NETANYAHU ST., OR YEHUDA, ISRAEL 60376
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001603207
About

Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the development and commercialization of treatments for cancer and immune-inflammatory diseases. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Or Yehuda, Israel.

Description

Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates include VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, as well as VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading